Cascadian Therapeutics, Inc. Stock Split Ratio

Cascadian Therapeutics, Inc. Stock Split Ratio

Cascadian Therapeutics, Inc. reported Stock Split Ratio of 600.00% for the 0-month period ending 2016-11-29, per its 10-Q filed 2017-11-08.

Discontinued › Notes › Equity › Stockholders' Equity Note

us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-11-08

• 2016-11-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 600.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 600.00%.